Association of interleukin-10, interferon-gamma, transforming growth factor-beta, and tumor necrosis factor-alpha gene polymorphisms with long-term kidney allograft survival

Iranian Journal of Kidney Diseases

Volumn 4, Issue 2, 2010, Pages 141-146

  Omrani, Davood ^a   Mokhtari, Mohammad Reza ^a   Bagheri, Morteza ^a   Ahmadpoor, Pedram ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetic polymorphism; Interferon gamma; Interleukin 10; Kidney transplantation; Transforming growth factor beta; Tumor necrosis factor alpha

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN SECRETION; SINGLE NUCLEOTIDE POLYMORPHISM;

GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953165102     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Tax WJ, Koene RA. Effector mechanisms in renal allograft rejection. Nephrol Dial Transplant. 1995;10:1569-71.
2. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet. 1999;26:1-3.
3. Omrani MD, Mokhtari MR, Tagizadae A, Bagheri M, Ahmad-Poor P. Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival. Iran J Immunol. 2008;5:201-6.
4. Hollegaard MV, Bidwell JL. Cytokine gene polymorphism in human disease: on-line databases, Supplement 3. Genes Immun. 2006;7:269-76.
5. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147:3815-22.
6. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol. 1992;148:3618-23.
7. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1-8.
8. Poole KL, Gibbs PJ, Evans PR, Sadek SA, Howell WM. Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. Transpl Immunol. 2001;8:259-65.
9. Bijlsma FJ, Bruggink AH, Hartman M, et al. No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation. Tissue Antigens. 2001;57:151-3.
10. Hahn AB, Kasten-Jolly JC, Constantino DM, et al. TNFalpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation. 2001;72:660-5.
11. Ruiz-Linares A. Dinucleotide repeat polymorphism in the interferon-gamma (IFNG) gene. Hum Mol Genet. 1993;2:1508.
12. Reynard MP, Turner D, Wadhwa M, Bird C, Navarrete CV. The influence of an IFN-gamma gene microsatellite on IFN-gamma production [abstract]. Immunology. 2000;61:S138.
13. Asderakis A, Sankaran D, Pravica V. High producer interferon gamma (IFNg) and interleukin 10 (IL-10) genotype is associated with increased frequency of acute rejection episodes in kidney transplant recipients. British Transplantation Society 1st Annual Congress; 1998.
14. Fujii D, Brissenden JE, Derynck R, Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986;12:281-8.
15. Zeller JC, Panoskaltsis-Mortari A, Murphy WJ, et al. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol. 1999;163:3684-91.
16. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014-20.
17. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1990;87:1233-7.
18. Brinkman BM, Giphart MJ, Verhoef A, et al. Tumor necrosis factor alpha-308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome. Hum Immunol. 1994;41:259-66.
19. Mayer FR, Messer G, Knabe W, Mempel W, Meurer M, Kolb HJ, Holler E. High response of TNF secretion in vivo in patients undergoing BMT may be associated with the 308 bp TNF-α gene enhancer polymorphism [abstract]. Bone Marrow Transplant. 1996;17:s101.
20. Azzawi M, Hasleton PS, Turner DM, et al. Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. Hum Immunol. 2001;62:140-2.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
22. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol. 2000;61:863-6.
23. Huang DR, Zhou YH, Xia SQ, Liu L, Pirskanen R, Lefvert AK. Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease. J Neuroimmunol. 1999;94:82-7.
24. Verjans GM, Brinkman BM, Van Doornik CE, Kijlstra A, Verweij CL. Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol. 1994;97:45-7.
25. Li Z, Habuchi T, Tsuchiya N, et al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Carcinogenesis. 2004;25:237-40.
26. Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int. 1999;56:281-8.
27. George S, Turner D, Reynard M, et al. Significance of cytokine gene polymorphism in renal transplantation. Transplant Proc. 2001;33:483-4.
28. Alakulppi NS, Kyllonen LE, Jantti VT, et al. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation. 2004;78:1422-8.
29. Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients. Transplantation. 2005;80:1773-82.
30. Marshall SE, McLaren AJ, Haldar NA, Bunce M, Morris PJ, Welsh KI. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation. 2000;70:1485-91.
31. Tajik N, Kazemi T, Delbandi A, Ghods A, Salek Moghaddam A. The Predictive Value of HLA-DR Matching and Cytokine Gene Polymorphisms in Renal Allograft Acute Rejection: a Living-unrelated Donor (LURD) Study. Iran J Immunol. 2006;3:150-6.
32. Breulmann B, Bantis C, Siekierka M, et al. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin Transplant. 2007;21:615-21.
33. Cartwright NH, Demaine AG, Hurlock NJ, et al. Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transpl Immunol. 2000;8:109-14.
34. Muller-Steinhardt M, Hartel C, Muller B, Kirchner H, Fricke L. The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int. 2002;62:1824-7.
35. Hutchings A, Guay-Woodford L, Thomas JM, et al. Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients. Pediatr Transplant. 2002;6:69-77.
36. Loucaidou M, Stitchbury J, Lee J, et al. Cytokine polymorphisms do not influence acute rejection in renal transplantation under tacrolimus-based immunosuppression. Transplant Proc. 2005;37:1760-1.
37. Tinckam K, Rush D, Hutchinson I, et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation. 2005;79:836-41.
38. Hutchinson IV, Pravica V, Perrey C, Sinnott P. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc. 1999;31:734-6.
39. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992;89:1890-3.
40. Wramner LG, Norrby J, Hahn-Zoric M, et al. Impaired kidney graft survival is associated with the TNF-alpha genotype. Transplantation. 2004;78:117-21.
41. Poli F, Boschiero L, Giannoni F, et al. Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation. Cytokine. 2000;12:1778-83.
42. Pelletier R, Pravica V, Perrey C, et al. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation. 2000;70:674-80.
43. Pawlik A, Domanski L, Rozanski J, et al. IL-2 and TNFalpha promoter polymorphisms in patients with acute kidney graft rejection. Transplant Proc. 2005;37:2041-3.